123 related articles for article (PubMed ID: 21889575)
1. Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury.
Meng QQ; Liang XJ; Wang P; Wang XP; Yang JW; Wu YF; Shen HY
Neurosci Lett; 2011 Oct; 503(3):191-5. PubMed ID: 21889575
[TBL] [Abstract][Full Text] [Related]
2. PPAR-
Meng QQ; Feng ZC; Zhang XL; Hu LQ; Wang M; Zhang HF; Li SM
Mediators Inflamm; 2019; 2019():6386729. PubMed ID: 31015796
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces secondary damage in experimental spinal cord injury.
Li X; Du J; Xu S; Lin X; Ling Z
J Int Med Res; 2013 Feb; 41(1):153-61. PubMed ID: 23569141
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
5. PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
Zhang Q; Hu W; Meng B; Tang T
Neurol Res; 2010 Oct; 32(8):852-9. PubMed ID: 20350367
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
7. PPAR-γ agonist rosiglitazone reduces autophagy and promotes functional recovery in experimental traumaticspinal cord injury.
Li H; Zhang Q; Yang X; Wang L
Neurosci Lett; 2017 May; 650():89-96. PubMed ID: 28433567
[TBL] [Abstract][Full Text] [Related]
8. The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury.
McTigue DM; Tripathi R; Wei P; Lash AT
Exp Neurol; 2007 Jun; 205(2):396-406. PubMed ID: 17433295
[TBL] [Abstract][Full Text] [Related]
9. Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury.
Yamaya S; Ozawa H; Kanno H; Kishimoto KN; Sekiguchi A; Tateda S; Yahata K; Ito K; Shimokawa H; Itoi E
J Neurosurg; 2014 Dec; 121(6):1514-25. PubMed ID: 25280090
[TBL] [Abstract][Full Text] [Related]
10. Recovery of spinal cord injury following electroacupuncture in rats through enhancement of Wnt/β-catenin signaling.
Zhang J; Li S; Wu Y
Mol Med Rep; 2017 Aug; 16(2):2185-2190. PubMed ID: 28627669
[TBL] [Abstract][Full Text] [Related]
11. Naringin may promote functional recovery following spinal cord injury by modulating microglial polarization through the PPAR-γ/NF-κB signaling pathway.
Li B; Mei XF
Brain Res; 2023 Dec; 1821():148563. PubMed ID: 37661010
[TBL] [Abstract][Full Text] [Related]
12. Melatonin alleviates acute spinal cord injury in rats through promoting on progenitor cells proliferation.
Zheng B; Hao D; Guo H; He B
Saudi Pharm J; 2017 May; 25(4):570-574. PubMed ID: 28579893
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
[TBL] [Abstract][Full Text] [Related]
14. Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.
Samantaray S; Das A; Matzelle DC; Yu SP; Wei L; Varma A; Ray SK; Banik NL
J Neurochem; 2016 May; 137(4):604-17. PubMed ID: 26998684
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo.
Morales-Garcia JA; Luna-Medina R; Alfaro-Cervello C; Cortes-Canteli M; Santos A; Garcia-Verdugo JM; Perez-Castillo A
Glia; 2011 Feb; 59(2):293-307. PubMed ID: 21125653
[TBL] [Abstract][Full Text] [Related]
16. Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury.
Meng QQ; Lei W; Chen H; Feng ZC; Hu LQ; Zhang XL; Li S
PPAR Res; 2018; 2018():3897478. PubMed ID: 30034460
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits inflammation after spinal cord injury via SIRT-1/NF-κB signaling pathway.
Zhao H; Mei X; Yang D; Tu G
Neurosci Lett; 2021 Sep; 762():136151. PubMed ID: 34352338
[TBL] [Abstract][Full Text] [Related]
18. Functional recovery, serotonergic sprouting, and endogenous progenitor fates in response to delayed environmental enrichment after spinal cord injury.
Koopmans GC; Deumens R; Honig WM; Hamers FP; Mey J; van Kleef M; Joosten EA
J Neurotrauma; 2012 Feb; 29(3):514-27. PubMed ID: 22026514
[TBL] [Abstract][Full Text] [Related]
19. Eugenol promotes functional recovery and alleviates inflammation, oxidative stress, and neural apoptosis in a rat model of spinal cord injury.
Ma L; Mu Y; Zhang Z; Sun Q
Restor Neurol Neurosci; 2018; 36(5):659-668. PubMed ID: 30040768
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
Sun H; Huang Y; Yu X; Li Y; Yang J; Li R; Deng Y; Zhao G
Int J Dev Neurosci; 2008 Aug; 26(5):505-15. PubMed ID: 18455351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
